rocklatan
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $855,329 | 5,194 | 3,192 |
| 2021 | $1.1M | 9,056 | 4,558 |
| 2020 | $995,330 | 6,040 | 3,093 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 573 | 48.3% |
| Food and Beverage | $542,044 | 19,101 | 18.4% |
| Consulting Fee | $482,221 | 161 | 16.4% |
| Unspecified | $373,202 | 46 | 12.7% |
| Travel and Lodging | $105,417 | 400 | 3.6% |
| Education | $9,200 | 5 | 0.3% |
| Grant | $9,000 | 2 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $2,850 | 2 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A MULTICENTER, OPEN-LABEL ROCKLATAN (NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% EVALUATION OF IOP LOWERING EFFICACY AND SAFETY AS REPLACEMENT OF CURRENT MEDICAL THERAPY REGIMEN FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION / MORE | Alcon Research LLC | $373,202 | 0 |
Top Doctors Receiving Payments for rocklatan — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , O.D | Optometrist | Pasadena, CA | $6,259 | 19 |
| , M.D | General Practice | Fresno, CA | $5,951 | 45 |
| , MD | Glaucoma Specialist | Phila, PA | $5,789 | 11 |
| , MD | Ophthalmology | Commack, NY | $5,745 | 9 |
| , M.D | Ophthalmology | El Paso, TX | $5,549 | 11 |
| , M.D | Ophthalmology | Queens Village, NY | $5,313 | 6 |
| , D.O | Ophthalmology | Dallas, TX | $5,173 | 15 |
| , MD | Ophthalmology | Memphis, TN | $5,150 | 37 |
| , MD | Ophthalmology | Irvine, CA | $5,141 | 7 |
| , MD | Ophthalmology | Brentwood, NY | $5,101 | 8 |
| , M.D | Ophthalmology | Las Vegas, NV | $4,887 | 12 |
| , M.D | Ophthalmology | Jacksonville, FL | $4,855 | 10 |
| , MD FACS | Ophthalmology | Bakersfield, CA | $4,698 | 11 |
| , MD | Ophthalmology | Alexandria, LA | $4,693 | 6 |
| , O.D | Optometrist | Houston, TX | $4,203 | 8 |
| , M. D | Ophthalmology | Vienna, VA | $4,202 | 6 |
| , M.D | Ophthalmology | Durham, NC | $4,180 | 1 |
| , MD | Ophthalmology | Radnor, PA | $4,180 | 1 |
| , M.D | Specialist | Houston, TX | $4,064 | 12 |
| , M.D | Ophthalmology | Bethpage, NY | $3,816 | 7 |
| , O.D | Optometrist | New York, NY | $3,509 | 12 |
| , O.D | Optometrist | Duncansville, PA | $3,499 | 11 |
| , M.D | Ophthalmology | Bellevue, WA | $3,440 | 7 |
| , MD | Glaucoma Specialist | New York, NY | $3,387 | 9 |
| , M.D., PH.D | Glaucoma Specialist | Mission Viejo, CA | $3,357 | 9 |
Manufacturing Companies
- Aerie Pharmaceuticals, Inc. $2.1M
- Alcon Vision LLC $482,127
- Alcon Research LLC $373,202
Product Information
- Type Drug
- Total Payments $2.9M
- Total Doctors 7,340
- Transactions 20,290
About rocklatan
rocklatan is a drug associated with $2.9M in payments to 7,340 healthcare providers, recorded across 20,290 transactions in the CMS Open Payments database. The primary manufacturer is Aerie Pharmaceuticals, Inc..
Payment data is available from 2020 to 2022. In 2022, $855,329 was paid across 5,194 transactions to 3,192 doctors.
The most common payment nature for rocklatan is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.4M, 48.3% of total).
rocklatan is associated with 1 research study, including "A MULTICENTER, OPEN-LABEL ROCKLATAN (NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% EVALUATION OF IOP LOWERING EFFICACY AND SAFETY AS REPLACEMENT OF CURRENT MEDICAL THERAPY REGIMEN FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION / MORE" ($373,202).